ERYtech Pharma Announces The Results Of Its Phase II Clinical Trial

ERYtech Pharma, the specialty pharmaceuticals company developing red cell-based medicinal products, announces the results of its phase II clinical trial. GRASPALL 2005-1 was presented orally on the 8th December 2008 at the 50th Annual Meeting of the American Society of Hematology in San Francisco (USA).

More: continued here

Filed under: Blood on December 19th, 2008